VERITS TL B1 1L USD 01/27/2023

Veritas Pharma Inc

Credit, Healthcare


Publicly traded companies mentioned herein: The Carlyle Group (CG), JPMorgan Chase and Co (JPM), Symantec Corporation (SYMC)

Highlights

The presenter is long the unsecured bonds of Veritas, and views them as total return investment. Veritas’ capital structure is made up of a $3.6B first lien, a $2.9B term loan, and $700M in secured bonds.The unsecured bonds currently trade at 93 and have the potential to earn 20% total return, They could trade to 10% over the next year and you’re creating the business at 5.5x.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.